AT188255T

Expression of biologically active platelet derived growth factor analogs in eucaryotic cells.

Abstract

Problem to be solved.To obtain a highly active PDGF analog factor by transducing a gene coding a B chain of a transfer promoter or PDGF and a gene containing a signal sequence capable of ordering secretion of the B chain to an eukaryotic cell.

Solution.In a method for producing a biologically active blood platelet- derived growth factor(PDGF) analog factor, a DNA component is capable of instructing expression and secretion of the biologically active PDGF analog factor in an eukaryotic cell and contains a transfer promoter and a B chain gene of PDGF on the downstream of the transfer promoter in which the gene codes a signal sequence capable of ordering the secretion of 67-175 amino acid of formula I and formula II, a B chain of human PDGF substantially homologous to the amino acids and a B chain of PDGF of the eukaryotic cell. Thereby, the chain B transduces the DNA component forming a protein having the same structure as that of PDGF and mitogen activity to a eukaryotic host cell, the host cell is grown in a medium and a product is isolated to give the objective factor.

Term

Term ended

Expired 10 October 2005, 21 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

58 members in 10 offices

This recordMember, by publication datePriority claim

Priority claims4

Priority claims
DocumentOfficeKindDate
66049684United States of AmericaA
70517585United States of AmericaA
492370CanadaA
617115CanadaA

Members58

Family members, oldest first
DocumentOfficeKind
EP0177957A2European Patent Office (EPO)A2
AU4845485AAustraliaA
JPS62278AJapanA
DK421787D0DenmarkD0
EP0177957A3European Patent Office (EPO)A3
DK421787ADenmarkA
AU7681687AAustraliaA
EP0259632A1European Patent Office (EPO)A1
JPS63119682AJapanA
US4766073AUnited States of AmericaA
US4769328AUnited States of AmericaA
US4801542AUnited States of AmericaA
US4845075AUnited States of AmericaA
US4849407AUnited States of AmericaA
US4889919AUnited States of AmericaA
AU5488590AAustraliaA
US5045633AUnited States of AmericaA
AU8695791AAustraliaA
EP0487116A1European Patent Office (EPO)A1
US5128321AUnited States of AmericaA
DE487116T1GermanyT1
EP0177957B1European Patent Office (EPO)B1
AT84312TAustriaT
ATE84312T1AustriaT1
US5187263AUnited States of AmericaA
DE3586960D1GermanyD1
DE3586960T2GermanyT2
AU638010B2AustraliaB2
AU641816B2AustraliaB2
US5428010AUnited States of AmericaA
US5474982AUnited States of AmericaA
EP0259632B1European Patent Office (EPO)B1
AT131532TAustriaT
ATE131532T1AustriaT1
JPH085797B2JapanB2
DE3751632D1GermanyD1
US5498600AUnited States of AmericaA
US5516896AUnited States of AmericaA
DE3751632T2GermanyT2
JPH10117790AJapanA
CA1340212CCanadaC
JP2837407B2JapanB2
NL990016I1Netherlands (Kingdom of the)I1
LU90408I2LuxembourgI2
NL990016I2Netherlands (Kingdom of the)I2
CA1340846ECanadaE
US6004929AUnited States of AmericaA
EP0487116B1European Patent Office (EPO)B1
AT188255TThis recordAustriaT
ATE188255T1AustriaT1
DE3588218D1GermanyD1
DE3588218T2GermanyT2
JP3145968B2JapanB2
CA1341398CCanadaC
DE19975042I2GermanyI2
EP0177957B2European Patent Office (EPO)B2
DE3586960T3GermanyT3
DK176036B1DenmarkB1